IRCT20200325046860N1 IRCT 2020-03-30 Darmanara .Co Convalescent Plasma therapy for COVID-19 Patients Evaluation of Convalescent Plasma as a Potential Therapy for COVID-19 infected patients 2020-03-15 anticipated 200 Complete https://irct.ir/trial/46759 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment, Other design features: Since convalescent plasma therapy in patients with COVID-19 disease has been approved by FDA as a investigational modality and being used in some other countries such as China and due to lack of curative medicine for the disease, this project will be performed in Iran as treatment for the patients. N/A COVID-19 Disease. Intervention 1: Treatment group: Patients with confirmed COVID-19 infection who in addition to their current treatment will be infused with 500 Ml convalescent plasma in 4 hrs. Intervention 2: Control group: Patients hospitalized with COVID-19 disease who are receive routine treatment. Yes - There is a plan to make this available What will be shared: It will be published as an article When: After printing the article To whom: All medical professionals Conditions: There is no restriction on access to information Where to obtain: 1- Dr. Hassan Abolghasemi, Baqiyatallah University of Medical Sciences 2- Dr Peyman Eshghi, IBTO How to obtain: Refer to the project supervisor Comments: